Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3943 Target Snapshot

Histamine H1 receptor · SINGLE PROTEIN · Cavia porcellus

1,224Compounds
358Assays
35Approved Drugs
878.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P31389. Use UniProt P31389 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P31389 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Histamine H1 receptor as ChEMBL target CHEMBL3943, mapped to UniProt P31389. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Histamine H1 receptor
SINGLE PROTEIN · Cavia porcellus
As of 2026-09-13
ChEMBL target ID
CHEMBL3943
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P31389
Histamine H1 receptor
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Histamine H1 receptor is the right protein anchor across sources, using UniProt P31389 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelHistamine H1 receptor
UniProt AccessionP31389
Component TypeProtein
Sequence Length488 aa

Histamine H1 receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Histamine H1 receptor, mapped to UniProt P31389. Sequence length is 488 aa.

Mapped IDP31389
Review nameHistamine H1 receptor
OrganismCavia porcellus
Clinical Profile

Clinical Phase Distribution

35
Approved
2
Phase III
9
Phase II
Assay Mix

Activity Type Distribution

IC50262.0
KI205.0
EC5099.0
KD312.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL2283398 10.22 IC50 0.0603 Preclinical
CHEMBL855 9.9 Kd 0.1259 Approved
CHEMBL366965 9.89 Ki 0.13 Preclinical
CHEMBL25626 9.59 IC50 0.26 Preclinical
CHEMBL534 9.51 Ki 0.31 Approved
CHEMBL534 9.5 Kd 0.3162 Approved
CHEMBL511 9.5 Kd 0.3162 Approved
CHEMBL65612 9.32 Ki 0.48 Preclinical
CHEMBL516 9.27 Ki 0.537 Approved
CHEMBL294777 9.2 Ki 0.63 Preclinical
Distribution

pChEMBL Value Distribution

44
5.0
64
5.5
90
6.0
95
6.5
91
7.0
90
7.5
67
8.0
29
8.5
36
9.0
7
9.5
pChEMBL
Approved Drugs

Approved Drugs

EPINASTINE
CHEMBL1106
Approved 2003
ARIPIPRAZOLE
CHEMBL1112
Approved 2002
ZIPRASIDONE
CHEMBL708
Approved 2001
KETOTIFEN
CHEMBL534
Approved 1999
QUETIAPINE
CHEMBL716
Approved 1997
EMEDASTINE
CHEMBL594
Approved 1997
OLOPATADINE HYDROCHLORIDE
CHEMBL1719
Approved 1996
OLANZAPINE
CHEMBL715
Approved 1996
ANTAZOLINE
CHEMBL1305
Approved 1994
RISPERIDONE
CHEMBL85
Approved 1993
LORATADINE
CHEMBL998
Approved 1993
EBASTINE
CHEMBL305660
Approved 1990
CLOZAPINE
CHEMBL42
Approved 1989
ASTEMIZOLE
CHEMBL296419
Approved 1988
TERFENADINE
CHEMBL17157
Approved 1985
TRIPROLIDINE
CHEMBL855
Approved 1982
PYRILAMINE
CHEMBL511
Approved 1973
HALOPERIDOL
CHEMBL54
Approved 1967
CYPROHEPTADINE
CHEMBL516
Approved 1961
CHLORPROMAZINE
CHEMBL71
Approved 1957
CHLORPHENIRAMINE
CHEMBL505
Approved 1950
CHLORPHENIRAMINE MALEATE
CHEMBL1659
Approved 1950
DIPHENHYDRAMINE
CHEMBL657
Approved 1946
HISTAMINE
CHEMBL90
Approved 1939
Assay Landscape

Assay Landscape

358
Total Assays
382
Tested Compounds
3
Assay Types
Functional — 213 assays, 262 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 167 252 7.0
assay format 43 10 8.0
organism-based format 3 0
Binding — 143 assays, 382 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 91 245 6.6
single protein format 24 49 7.0
assay format 11 12 6.8
organism-based format 9 1 7.6
cell membrane format 5 59 7.1
cell-based format 3 16 5.3
ADME — 2 assays, 9 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 1 5 6.9
tissue-based format 1 4 6.9

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine